chrisvoncsefalvay/vaers-outcomes huggingface dataset:
top of my shoulder is really sore; substantial swelling left side of neck / a lot of swelling between my neck and rotator cuff; front lymph node above collarbone bulging out and looks bruised; looks bruised; This is a spontaneous report from a non-contactable consumer (patient). A 48-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Lot number: EN6203; Expiration date was not reported), via an unspecified route of administration in the left arm on 24Feb2021 08:00 AM (at the age of 48-years-old) as dose 2, single for COVID-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing. Concomitant medications included Vitamin D and ibuprofen (ADVIL); both taken for an unspecified indication, start and stop dates were not reported. The patient was previously vaccinated with BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Lot number: EL9269; Expiration date was not reported) via an unspecified route of administration in the left arm on 03Feb2021 08:00 AM (at the age of 48-years-old) as dose 1, single for COVID-19 immunisation. No other vaccine was received by the patient in four weeks. The patient had no COVID prior vaccination and was not tested for COVID post vaccination. The patient has no known allergies. The patient experienced substantial swelling left side of neck, front lymph node above collarbone bulging out and looks bruised on 25Feb2021 08:00 AM (reported as 24 hours after injection). 48 hours after injection, swelling down slightly and still see the lymph node. The patient experienced top of her shoulder was really sore, felt a lot of swelling between her neck and rotator cuff on 26Feb2021 14:00 (54 hours since injection). No treatment was received for the events. The outcome of the events was not recovered. The patient was querying on how she would know if there was permanent damage; patient haven't yet been seen and doesn't mean she won't be if this continues.   No follow-up attempts are possible. No further information is expected.
pt recv vax  & later noticed aching all over, fever, nausea, 14hr p/vax vomiting x 2, flu like sx;
I began my menstrual cycle, which tends to be on the first of the month for 1-2 days every 2-3 months. Instead, it has lasted for a week and was on a date that was atypical. Significant menstrual cramps and pain as well.
Had normal results following injection for two days, everything was fine. Then one week later woke from sleep around 2am with sore arm, then area became swollen (and hard lump approx. 2", but sore approx. 3" injection area), mild redness, mild itch occasionally, some mild muscle aches, also mild fasciculations in lower legs.
I felt fine all afternoon and evening. Went to bed at 1:00 AM. I woke up at 2:00 AM with teeth rattling shivers. I?m drinking non-caffeine green tea hoping to reduce the shivers.
Very bad headache 30 minutes after vaccine. The next morning had hearing issues with ringing in ears and echoing, especially of my young child's voice.
Rash on chest; MILD HEADACHE; A report was received from a consumer concerning a female patient participating in the mRNA-1273 Emergency Use Program and experienced a headache and rash on chest.   The patient's medical history, as provided by the reporter, included having experienced rashes from viral infections or in some cases from vaccines, to include this year's flu vaccine. No relevant concomitant medications were reported.   On 08 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number unknown) intramuscularly for prophylaxis of COVID-19 infection.   The reporter reached out on behalf of his wife who received the vaccine on 08 Jan 2021. The next day, she had a mild headache, and the day after, 10 Jan 2021 she developed a rash on her chest. No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events was unknown/not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
On 10/08/2022, Pt. sent e-mail stating it has been 23 days post 1st Jynneos vaccine on the Left forearm.  Pt. reports injection site is still red and bruised with obvious skin discoloration and scarring. Patient expresses concern about permanent discoloration or scarring of the Jynneos vaccine.  Pt. has cancelled the 2nd Jynneos vaccine originally scheduled for 10/13/2022.
This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 23-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 49-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis. No Medical History information was reported. On 23-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 23-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 23-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 23-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 23-Jul-2022). No concomitant medications were provided by the reporter. Patient received half dose. On 04-Jun-2022 the vials were initially stored in the refrigerator. Vial did not undergone any temperature excursions. No treatment medications were provided by the reporter.
Left arm had increased Swelling; Left arm was set on fired; Left arm  had increased pain; This spontaneous case was reported by a patient and describes the occurrence of PERIPHERAL SWELLING (Left arm had increased Swelling), BURNING SENSATION (Left arm was set on fired) and PAIN IN EXTREMITY (Left arm  had increased pain) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 013M20A) for COVID-19 prophylaxis.     Patient had no known drug allergies. Patient had no alcohol use and drug use as past medical history. Patient had no pertinent family history. No other vaccines given on the same day or within one month prior to Moderna COVID-19 vaccine.  The patient's past medical history included Ex-smoker (Tobacco Use, Former smoker), Cataract extraction, Gallbladder operation NOS, Hernia repair and Colonoscopy (Colonoscopy Screening) in May 2019. Concurrent medical conditions included Heart disease, unspecified, Hypertension, Hypothyroidism and Adhesive capsulitis of shoulder (Adhesive capsulitis of left shoulder (M75 02)). Concomitant products included METHYLPREDNISOLONE, TRAMADOL HCL, LEVOTHYROXINE SODIUM (EUTHYROX), ERGOCALCIFEROL (VITAMIN D [ERGOCALCIFEROL]), OLMESARTAN MEDOXOMIL and ATENOLOL for an unknown indication.   On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Left arm had increased Swelling), BURNING SENSATION (Left arm was set on fired) and PAIN IN EXTREMITY (Left arm  had increased pain). At the time of the report, PERIPHERAL SWELLING (Left arm had increased Swelling), BURNING SENSATION (Left arm was set on fired) and PAIN IN EXTREMITY (Left arm  had increased pain) outcome was unknown.            Patient received the booster dose.  Concomitant medications also included Pdeudoeph-Bromphen-DM (30-2-10MG/5 Ml Syrup Oral).  Patient was encouraged to take the booster dose after getting COVID on 03-Aug-2021 since patient has cardiovascular disease.  On 02-Sep-2021, patient took the Flu vaccine.  No treatment medications were provided.   This case was linked to MOD-2021-286668 (Patient Link).
Found out I was pregnant in early may, miscarried on june 6 2021. Pregnant again  Sept 5, 2021, had ultrasound that showed heartbeat. No heartbeat 10/8/21, d and c on 10/12/21. Referred to doc. Fertility work up done and APS was suggested as possible reason for miscarriages but would need follow up test to confirm, testing done and indicative of APLS  in conjunction with multiple miscarriages
Swelling of the left thigh, erythema  6 1/2" x 4" reported after injection. Temperature 100.5 per mom.
Janssen on 8/17. Positive 8/29. death at end hospital stay
BODY ACHES; EYES HURT AND WERE SENSITIVE TO LIGHT; MUSCLE CRAMPS; EYES HURT; BRUISE AT INJECTION SITE; RASH AT INJECTION SITE; WEAKNESS; TIREDNESS; EXTREME HEADACHE; FEVER; This spontaneous report received from a patient concerned a 30 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018 expiry: UNKNOWN) dose was not reported, once a total administered on 23-MAR-2021 vaccinated at left arm, for prophylactic vaccination. No concomitant medications were reported. On 24-MAR-2021, the subject experienced body aches. On 24-MAR-2021, the subject experienced eyes hurt and were sensitive to light. On 24-MAR-2021, the subject experienced muscle cramps. On 24-MAR-2021, the subject experienced eyes hurt. On 24-MAR-2021, the subject experienced bruise at injection site. On 24-MAR-2021, the subject experienced rash at injection site. On 24-MAR-2021, the subject experienced weakness. On 24-MAR-2021, the subject experienced tiredness. On 24-MAR-2021, the subject experienced extreme headache. On 24-MAR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, extreme headache, muscle cramps, eyes hurt and were sensitive to light, bruise at injection site, rash at injection site, weakness, tiredness, body aches and eyes hurt was not reported. This report was non-serious.
Went to bed around 10pm the night I got the shot feeling a bit achy. Woke up at 12:08am with bad chills was not able to stop shivering. That lasted about 30 to 45 minutes. Checked my temp it was 101.3 very very achy and nauseous at that time. I felt very uncomfortable with a bad headache. Checked my temp again around 2:30 am it was 102.1 chills went away but still very nauseous and bad headache was not able to sleep. Around 4am I took 2 Tylenol and took my temp it was 103 still felt very bad. Temp finally started to go back down around 8am by 10 it was down to 98.9 but still felt nauseous but was able to get my headache under control. My temp did go back up to 100  around 1pm but after I took a shower it went back down. As of today 10/2/21 7:24pm my temp is back to normal have a bit of a headache that comes and goes and I have no energy at all. I have not been able to go to work due to feeling so bad.
expired doses administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired doses administered) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired doses administered). On 29-Oct-2021, EXPIRED PRODUCT ADMINISTERED (expired doses administered) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test: 800-900 (Inconclusive) the patients antibody numbers were in the 800-900 range..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The doctors did not knowa 30-day expiration date applied to vaccines kept in the refrigerator. These vaccine was administered  to patient after 30-day mark.   It was reported that the patient did not report any adverse events or symptoms.   No concomitant medications were reported.  No treatment information was reported.   This case was linked to MOD-2021-415889 (Patient Link).
Information has been received from a nurse concerning a multiple patient (gender and age unknown). On an unknown date, the patients were vaccinated with varicella virus vaccine live (unspecified). No other co-suspects were reported. No concomitant medications were reported. It was reported that their county was experienced an outbreak of chickenpox. The nurse believed that there or may be more previously vaccinated patients who may have developed chickenpox. The reporter stated that this county had a very high rate of parents who opt-out of vaccines. At the time of the report, the outcome of chickenpox was unknown. The relatedness for chickenpox was unknown for varicella virus vaccine live (unspecified). Additional information has been requested. This is one of the several reports of the same source,
Arthralgia, NauseaVomiting, Lightheadedness Narrative:
Alcohol use disorder, severe, dependence. Behavioral health admit to the hospital after ED visit. This visit was within 6 weeks of receiving the COVID vaccine.
After dose one she experienced left toe swelling and she could hardly walk./left toe swelled up so much that she could hardly walk; After dose one she experienced left toe swelling and she could hardly walk./left toe swelled up so much that she could hardly walk; fatigue; This is a spontaneous report from contactable consumer (patient).   A 63-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: ER8731, Expiration date: Unknown), via an unspecified route in her left arm on 18Apr2021 at around 13:00, as a single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. Patient did not receive any other vaccinations within four weeks prior to the administration of the first dose. On unknown date Apr2021, after first dose, patient experienced left toe swelled up so much that she could hardly walk. She went to an urgent care (physician office) and told the staff she had received the Covid 19 vaccine but the staff at the urgent care didn't seem to think her swollen toe was related to the Covid 19 vaccine. She also experienced fatigue, so she saw her primary care doctor. It was time for her regular appointment. Therapeutic measures taken as a result of the events included antibiotic which she was prescribed. The patient underwent lab test and procedure which included some routine blood work done, urinalysis and EKG. The clinical outcome of the events was everything came back normal. She was feeling better outcome was unknown.  Follow-up (28May2021): New information received from a contactable consumer included: updated information regarding events after first dose and second dose, time of administration of both doses update and event details about the second dose updated.  No follow-up attempts are possible. No further information is expected.
Initial report was retrieved from the scientific literature on 30 November 2010. A 42-year-old male patient received an injection of H1N1 (lot number UP005A) on 22 October 2009. The patient was bedridden and resided in a long-term care facility; medical history included tonic-clonic epilepsy and spastic quadriplegia, for which he was treated with an anticonvulsant and tranquilizer. He had a feeding gastrostomy. He experienced no vaccine-related adverse events following vaccination, and had previously received inactivated trivalent seasonal influenza vaccine (2000 through 2009) and pneumococcal vaccine. On Day 41 following vaccination, he suddenly became seriously ill with a fever and hypoxemia. He had no cough, rhinorrhea, jaundice, rash or diarrhea; pharynx was not injected or edematous. A nasopharyngeal swab, using rapid-enzyme immunoassay, was positive for influenza A, and subsequent reverse transcriptase-polymerase chain reaction was positive for influenza A subtype H1 swine-like virus (wild type pH1N1). The patient was treated with OSELTAMIVIR and supplemental oxygen, and kept in a single-patient room with droplet and standard infection-control precautions. On Day 2 of his illness, the patient experienced greater respiratory distress. Leukocyte count was 15,5000 uL (normal 4000-10, 5000 uL), and a chest radiograph at that time revealed right middle and upper lobe pneumonia. He was treated with intravenous antibiotics, and subsequent radiographs showed improvement by Day 9; the patient was considered to be fully recovered on Day 22.
Per mom states feet swollen bilat. approx 1-2 hours after 2 min shots given. Feet warm, feet swollen like balloons. Advised Dr of this at visit 10/7/08.
This spontaneous report as received from a certified medical assistant refers to an approximately 23 year old female patient with non Hodgkin's lymphoma B cell stage 3 and no drug reactions/allergies. On an unspecified date the patient was vaccinated with first dose of GARDASIL (0.5ml, intramuscular) (lot number 660612/0229X, expired date 30-OCT-2010). On 22-OCT-2008, the patient was vaccinated with second dose of GARDASIL (0.5ml, intramuscular) (lot number 661044/0548X, expired date 29-NOV-2010). On 08-JAN-2009, the patient was vaccinated with third dose of GARDASIL (0.5ml, intramuscular) (lot number unspecified). The reason the patient received the GARDASIL series was for prevention as well as the patient had a "low grade pap smear" in 2007. The certified medical assistant reported that the patient was diagnosed with breast cancer in 2011. She stated that the patient was "in and out" of the hospital on unspecified dates at an unspecified hospital after she was diagnosed with the breast cancer. She also reported that the patient had been seen by an unspecified oncologist on unspecified dates. The certified medical assistant also reported that the patient "recently" had a bone marrow transplant on an unspecified date. She stated that the patient was re-administered all of her "childhood vaccines" (vaccines unspecified) on an unspecified date after her bone marrow transplant. The certified medical assistant reported that the patient's medication list "from October 2013" showed that the patient was on an unspecified birth control pill and ibuprofen. The certified medical assistant reported that she was unsure if the patient was still currently taking those medications. The outcome of the patient was unknown. The causality was not provided. Upon internal review, breast cancer and bone marrow transplant were considered to be other important medical events. Additional information has been requested.
Swelling lips; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (Swelling lips) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced LIP SWELLING (Swelling lips). At the time of the report, LIP SWELLING (Swelling lips) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
Patient stated red rash developed down entire left arm 1 day following vaccination and persisted for 3 days after. Patient reported to us 7 days following vaccination stating that rash has resolved now. She went to her doctor who told her to take diphenhydramine prior to next dose.
Blood Clot right side of brain.  No symptoms.  Total loss of function on entire left side.  Treated for stroke(TPA Drip).  ICU 3 days.  Determined not to be stroke-no evidence on brain scan.  Heart Chamber now enlarged.
Information has been received from a lawyer regarding a case in litigation concerning a patient (age and gender unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On or about 24-SEPTEMBER-2009, the patient was vaccinated with ZOSTAVAX, (lot# and route unknown), at a healthcare facility/office (by an unspecified healthcare professional) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. In 2016, the patient was treated (by an unspecified healthcare professional) at a medical center, for a persistent and severe vesicular rash, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The reporter considered the events to be related to ZOSTAVAX. The outcome of the events was unknown. Additional information has been requested.
PATIENT FALL ON THE FLOOR AFTER THE FLU VACCINE ADMINISTRATION. SHE FELT DIZZY FOR MORE THAN 10 MINUTES. CALLED 911.
Initial presentation with mild hives. Over next two months progression to severe hives spread over whole body.
Patient became dizzy 10 minutes after administration of her second Moderna COVID vaccine. She stated that it is something that happens to her sometimes and she just needed to drink some juice. The gentleman with her got her a bottle of orange juice, and she drank it all. Ten minutes later she said she was still a little bit dizzy but was feeling better. They wanted to leave at that point, saying that she was used to this and the man with her was an EMT that could care for her if her dizziness worsened. I asked them to stay another few minutes, which they did and then decided to leave before I could check in with them again. I spoke to the patient this evening and she said she is still feeling a little dizzy. I advised her to contact her doctor if she is still feeling dizzy tomorrow or if the dizziness worsens.